MyFinsight
Home
About
Contact
evfm: the income statement
Download
Download image
Net loss
attributable to common...
-$1,680K
(29.11%↑ Y/Y)
Convertible and redeemable
preferred stock deemed...
$111K
Net loss
-$1,569K
(33.66%↑ Y/Y)
Income tax benefit
(expense)
-$4K
(50.00%↑ Y/Y)
Product sales, net
$4,952K
(10.14%↑ Y/Y)
Loss before income
tax benefit...
-$1,573K
(33.71%↑ Y/Y)
Income (loss) from
operations
$951K
(138.98%↑ Y/Y)
Total operating
expenses
$4,001K
(-42.32%↓ Y/Y)
Gain on change in
accounting estimates on...
$1,933K
Total other income
(expense), net
-$2,524K
(-3867.16%↓ Y/Y)
Interest income
$3K
(0.00%↑ Y/Y)
General and
administrative
$2,088K
(-31.59%↓ Y/Y)
Selling and marketing
$2,391K
(0.38%↑ Y/Y)
Research and
development, net
$470K
Amortization of intangible
asset
$80K
(-73.42%↓ Y/Y)
Cost of goods sold
$905K
(4.14%↑ Y/Y)
Change in fair value of
financial instruments
-$1,845K
(-339.92%↓ Y/Y)
Other expense, net
$682K
(21.35%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Evofem Biosciences, Inc. (EVFM)
Evofem Biosciences, Inc. (EVFM)